Feed Preview

Nanoparticle Delivery

Nanoparticle Delivery diagram by Zherebetskyy, Wikimedia
Zherebetskyy, Wikimedia

Nanoparticles enable the delivery of substances, including nucleic acids and chemotherapeutic drugs, to a targeted region while sparing healthy tissues, thus overcoming adverse systemic effects of gene therapy or drug delivery. Here is the latest research on nanoparticle delivery.

Top 20 most recent papers
Materials Science & Engineering. C, Materials for Biological Applications

Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor

Materials Science & Engineering. C, Materials for Biological ApplicationsMarch 25, 2020
Abhalaxmi SinghSanjeeb Kumar Sahoo
Accounts of Chemical Research

Cyclodextrin Metal-Organic Frameworks: From the Research Laboratory to the Marketplace

Accounts of Chemical ResearchMarch 18, 2020
Indranil RoyJ Fraser Stoddart
Nature Medicine

STAR particles for enhanced topical drug and vaccine delivery

Nature MedicineMarch 11, 2020
Andrew R TadrosMark R Prausnitz
ACS Applied Materials & Interfaces

Magnetic Particle Spectroscopy (MPS) for Detection of Influenza A Virus Subtype H1N1

ACS Applied Materials & InterfacesMarch 10, 2020
Kai WuJian-Ping Wang
International Journal of Nanomedicine

An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis

International Journal of NanomedicineMarch 27, 2020
Sebastian P PernalHerbert H Engelhard
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences

Sugar-Based Colloidal Nanocarriers for Topical Meglumine Antimoniate Application to Cutaneous Leishmaniasis Treatment: Ex vivo Cutaneous Retention and In vivo Evaluation

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical SciencesMarch 8, 2020
Thais Aragão HoroiwaAdriano M Oliveira
Advanced Drug Delivery Reviews

Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing

Advanced Drug Delivery ReviewsMarch 10, 2020
Hao TangXingyu Jiang

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2020 Meta ULC. All rights reserved